Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 64
Filtrar
2.
Rev. esp. anestesiol. reanim ; 70(6): 362-365, Jun-Jul. 2023. tab
Artigo em Espanhol | IBECS | ID: ibc-221252

RESUMO

Paciente de 26 años afecto de ataxia de Friederich con una miocardiopatía hipertrófica no obstructiva sometido a una tiroidectomía total por una tirotoxicosis secundaria a amiodarona persistente (a pesar de elevadas dosis de antitiroideos y corticoides), que intraoperatoriamente presentó un episodio sugestivo de tormenta tiroidea.La tormenta tiroidea es una urgencia endocrinológica que asocia una elevada morbimortalidad. Para mejorar la supervivencia es de vital importancia un diagnóstico temprano y un tratamiento precoz que incluya: un tratamiento sintomático, el tratamiento de las manifestaciones cardiovasculares, neurológicas y/o hepáticas y de la tirotoxicosis, así como suprimir o evitar estímulos desencadenantes y practicar un tratamiento definitivo.(AU)


A 26-year-old patient with Friederich's ataxia with hypertrophic obstructive cardiomyopathy undergoing a total thyroidectomy due to persistent amiodarone-induced thyrotoxicosis (despite high doses of antithyroid drugs and corticosteroids), presented an intraoperative episode suggestive of thyroid storm.Thyroid storm is an endocrine emergency that is associated with high morbimortality. Early diagnosis and treatment, which is of vital importance to improve survival. Treatment includes: symptomatic treatment, treatment of cardiovascular, neurological, and/or hepatic manifestations and thyrotoxicosis, measures to suppress or avoid triggering stimuli, and definitive treatment.(AU)


Assuntos
Humanos , Masculino , Adulto , Ataxia de Friedreich/complicações , Ataxia de Friedreich/tratamento farmacológico , Crise Tireóidea/complicações , Crise Tireóidea/tratamento farmacológico , Cardiomiopatia Hipertrófica , Tireotoxicose , Amiodarona , Anestesia , Anestesiologia , Resultado do Tratamento , Pacientes Internados , Exame Físico , Avaliação de Sintomas
3.
Artigo em Inglês | MEDLINE | ID: mdl-37276964

RESUMO

A 26-year-old patient with Friederich's ataxia with hypertrophic obstructive cardiomyopathy undergoing total thyroidectomy due to persistent amiodarone-induced thyrotoxicosis (despite high doses of antithyroid drugs and corticosteroids), presented an intraoperative episode suggestive of thyroid storm. Thyroid storm is an endocrine emergency that is associated with high morbidity and mortality. Early diagnosis and treatment, which is of vital importance to improve survival, includes symptomatic treatment, treatment of cardiovascular, neurological, and/or hepatic manifestations and thyrotoxicosis, measures to suppress or avoid triggering stimuli, and definitive treatment.


Assuntos
Anestésicos , Crise Tireóidea , Tireotoxicose , Humanos , Adulto , Crise Tireóidea/complicações , Crise Tireóidea/diagnóstico , Crise Tireóidea/tratamento farmacológico , Tireotoxicose/complicações , Tireotoxicose/cirurgia , Tireotoxicose/induzido quimicamente , Ataxia/complicações , Ataxia/tratamento farmacológico , Antitireóideos/efeitos adversos , Anestésicos/efeitos adversos
8.
J Investig Allergol Clin Immunol ; 33(3): 179-189, 2023 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-35029151

RESUMO

OBJECTIVES: To assess the degree of consensus among a multidisciplinary expert panel on the transition of adolescents with severe asthma from pediatric to adult care. METHODS: A 61-item survey was developed based on guidelines for other chronic diseases, covering transition planning, preparation, effective transfer, and follow-up. A 2-round Delphi process assessed the degree of consensus among 98 experts (49 pediatricians, 24 allergists, and 25 pulmonologists). Consensus was established with ≥70% agreement. RESULTS: Consensus was reached for 42 items (70%). Panelists were unable to agree on an age range for initiation of transition. The main goal during the transition identified by the experts is for adolescents to gain autonomy in managing severe asthma and prescribed treatments. The panelists agreed on the importance of developing an individualized plan, promoting patient autonomy, and identifying factors associated with the home environment. They agreed that the adult health care team should have expertise in severe asthma, biologics, and management of adolescent patients. Pediatric and adult health care teams should share clinical information, agree on the criteria for maintaining biological therapy, and have an on-site joint visit with the patient before the effective transfer. Adult health care professionals should closely follow the patient after the effective transfer to ensure correct inhaler technique, adherence, and attendance at health care appointments. CONCLUSION: This consensus document provides the first roadmap for Spanish pediatric and adult teams to ensure that key aspects of the transition process in severe asthma are covered. The implementation of these recommendations will improve the quality of care offered to the patient.


Assuntos
Asma , Transição para Assistência do Adulto , Humanos , Adolescente , Adulto , Criança , Consenso , Espanha , Asma/tratamento farmacológico , Terapia Biológica
9.
J Investig Allergol Clin Immunol ; 32(4): 270-281, 2022 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-33884956

RESUMO

BACKGROUND AND OBJECTIVE: Nut allergy is a growing problem, yet little is known about its onset in children. Objective: To characterize the onset of nut allergy in children in southern Europe. METHODS: The study population comprised consecutive patients up to 14 years of age who visited allergy departments with an initial allergic reaction to peanut, tree nut, or seed. The allergy work-up included a clinical history, food challenge, skin prick testing, determination of whole-extract sIgE, and ImmunoCAP ISAC-112 assay. RESULTS: Of the 271 children included, 260 were first diagnosed with nut allergy at a mean age of 6.5 years and at a mean (SD) of 11.8 (21.2) months after the index reaction. The most common culprit nuts at onset were walnut (36.5%), peanut (28.5%), cashew (10.4%), hazelnut (8.5%), pistachio (5.4%), and almond (5%). Onset of peanut allergy was more frequent in children ≤6 years and walnut in those aged >6 years (P=.032). In 65% of cases, the allergic reaction occurred the first time the patient consumed the nut, and 35% of reactions were anaphylactic. Overall, polysensitization to nuts was detected by skin prick testing in 64.9% of patients, although this rate was lower among walnut-allergic children (54.7%) and peanut-allergic children (54.1%) (P<.0001). Sensitization to 2S albumins was predominant (75%), especially Jug r 1 (52.8%), whereas sensitization to lipid transfer proteins was less relevant (37%). CONCLUSION: In the population we assessed, the onset of nut allergy occurred around 6 years of age, slightly later than that reported in English-speaking countries. Walnut was the main trigger, followed by peanut. 2S albumin storage proteins, especially Jug r 1, were the most relevant allergens. This study will help guide management and may contribute to preventive strategies in pediatric nut allergy.


Assuntos
Juglans , Hipersensibilidade a Noz , Hipersensibilidade a Amendoim , Alérgenos , Arachis , Criança , Humanos , Imunoglobulina E , Hipersensibilidade a Noz/diagnóstico , Hipersensibilidade a Noz/epidemiologia , Nozes , Hipersensibilidade a Amendoim/diagnóstico , Testes Cutâneos
14.
J Investig Allergol Clin Immunol ; 29(2): 94-102, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30457105

RESUMO

The emergence of new technology enables allergists and patients to compile data and receive feedback regarding key symptoms, risk behavior, and/or management. The term "eHealth" refers to a diverse group of tools that use computerized technologies to improve both the efficacy and the efficiency of the health care industry. eHealth comprises a variety of technologies, as follows: mobile devices (mHealth) in medical care, including electronic diaries, wearable sensors, and adherence monitoring; health informatics (eg, electronic health records, computerized physician order entry, clinical decision support); telemedicine, which is the use of information and communication technologies for the management of diseases and medical education; social media platforms, and the analysis of information acquired through these platforms using "big data" technologies. In this review, we summarize the latest findings on the use of eHealth technology and the relevance of eHealth to allergic conditions.


Assuntos
Hipersensibilidade , Informática Médica , Telemedicina , Humanos , Hipersensibilidade/diagnóstico , Hipersensibilidade/epidemiologia , Hipersensibilidade/prevenção & controle , Hipersensibilidade/terapia , Informática Médica/métodos , Mídias Sociais , Telemedicina/métodos
15.
J. investig. allergol. clin. immunol ; 29(2): 94-102, 2019. ilus, tab, graf
Artigo em Inglês | IBECS | ID: ibc-184051

RESUMO

The emergence of new technology enables allergists and patients to compile data and receive feedback regarding key symptoms, risk behavior, and/or management. The term "eHealth" refers to a diverse group of tools that use computerized technologies to improve both the efficacy and the efficiency of the health care industry. eHealth comprises a variety of technologies, as follows: mobile devices (mHealth) in medical care, including electronic diaries, wearable sensors, and adherence monitoring; health informatics (eg, electronic health records, computerized physician order entry, clinical decision support); telemedicine, which is the use of information and communication technologies for the management of diseases and medical education; social media platforms, and the analysis of information acquired through these platforms using "big data" technologies.In this review, we summarize the latest findings on the use of eHealth technology and the relevance of eHealth to allergic conditions


La aparición de nuevas tecnologías conlleva para los alergólogos y los pacientes la posibilidad de recopilar datos y recibir información directa sobre los síntomas clave de las enfermedades, los comportamientos de riesgo y/o su manejo. El término "eHealth", o salud electrónica, se refiere a un grupo diverso de herramientas que utilizan tecnologías informáticas para mejorar la eficacia y la eficiencia de la industria de la salud. La "eHealth" comprende varias tecnologías, como el uso de dispositivos móviles aplicados a la salud ("mHealth"), incluyendo diarios electrónicos, sensores ponibles o monitorización de la adherencia terapéutica; la informática biomédica (por ejemplo, la historia clínica electrónica, la prescripción electrónica o los sistemas de ayuda a las decisiones clínicas); la telemedicina, que es el uso de las tecnologías de la información y la comunicación para el manejo de enfermedades y de educación sanitaria; las plataformas de redes sociales, y el análisis de la información adquirida a través de estas plataformas, usando técnicas de "big data" o inteligencia de datos. En esta revisión, resumimos la evidencia que rodea al uso de tecnologías "eHealth" y su relevancia para las enfermedades alérgicas


Assuntos
Humanos , Telemedicina/tendências , Asma/tratamento farmacológico , Consulta Remota/tendências , Hipersensibilidade/tratamento farmacológico , Asma/diagnóstico , Aplicativos Móveis/tendências , Big Data/provisão & distribuição , Políticas de eSaúde , Rede Social , Hipersensibilidade/diagnóstico
19.
Radiología (Madr., Ed. impr.) ; 60(2): 171-174, mar.-abr. 2018. ilus
Artigo em Espanhol | IBECS | ID: ibc-174079

RESUMO

La inflamación de las glándulas salivales secundaria a la administración de contraste yodado es una reacción adversa muy poco frecuente. Su etiología no está aclarada y, aunque tiene un curso benigno, se han descrito complicaciones asociadas. Presentamos dos casos de submaxilitis aguda bilateral como reacción adversa tras la administración intravenosa de contraste yodado en dos varones de 60 y 63 años de edad a los que se realizó en los días previos una tomografía computarizada


Swelling of the salivary glands after administration of iodinated contrast is a very rare adverse reaction. Its etiology is not clear and although it has a benign course associated complications have been reported. We report two cases of acute bilateral sialadenitis after intravenous iodinated contrast in 60 and 63 year-old men who underwent a computed tomography scan in the previous days


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Sialadenite/complicações , Sialadenite/diagnóstico por imagem , Compostos de Iodo/efeitos adversos , Corticosteroides/uso terapêutico , Sialadenite/induzido quimicamente , Glândulas Salivares , Glândulas Salivares/diagnóstico por imagem , Meios de Contraste/efeitos adversos , Vértebras Cervicais/diagnóstico por imagem , Vértebras Cervicais/lesões , Diagnóstico Diferencial
20.
Radiologia (Engl Ed) ; 60(2): 171-174, 2018.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28619517

RESUMO

Swelling of the salivary glands after administration of iodinated contrast is a very rare adverse reaction. Its etiology is not clear and although it has a benign course associated complications have been reported. We report two cases of acute bilateral sialadenitis after intravenous iodinated contrast in 60 and 63 year-old men who underwent a computed tomography scan in the previous days.


Assuntos
Meios de Contraste/efeitos adversos , Iohexol/efeitos adversos , Sialadenite/induzido quimicamente , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...